GGrantIndex
← Leaderboards

Joseph M Backer

Sibtech, Inc.

Google Scholar ↗PubMed ↗ORCID ↗
$9,109,535
Attributed
$12,245,253
Total exposure
18
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY2005–19
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$12,245,253 · 18

By mechanism

R44$6,482,557 · 5
R01$2,868,681 · 1
R43$2,164,363 · 10
R21$729,652 · 2

Top collaborators

Others in their field

Top investigators on “Vascular Endothelial Growth Factors”

Research focus

Vascular Endothelial Growth FactorsSiteImageTumorAngiogenesis InhibitorsVascular Endothelial Growth Factor ReceptorPre-ClinicalAngiogenesisReceptorMonitorBaseResponsePharmaceutical PreparationsLigandsMediatingMolecular ImagingProteinsInhibitor/AntagonistPositron-Emission TomographyTumor GrowthRadiolabeledRadiotracerIn VivoMalignant Neoplasms

Grant awards (31)

Fluorescent Nanodiamonds for Multiplexed Imaging and Diagnostics$55,000
R43 · FY2019 · CA
Fluorescent Nanodiamonds for Multiplexed Imaging and Diagnostics$291,083
R43 · FY2018 · CA
Imaging VEGFR-1 in early metastatic lesions$175,079
R21 · FY2018 · CA
Imaging VEGFR-1 in early metastatic lesions$229,436
R21 · FY2017 · CA
Clinical development of 18F PET tracer for imaging VEGF receptors$456,892
R44 · FY2016 · CA · contact PI
Clinical development of 18F PET tracer for imaging VEGF receptors$1,016,118
R44 · FY2015 · CA · contact PI
Image-guided combination therapy: noninvasive assessment of delivery and response$562,844
R01 · FY2015 · CA
Targeted drug delivery to tumor microenvironment$224,833
R43 · FY2015 · CA · contact PI
Image-guided combination therapy: noninvasive assessment of delivery and response$550,634
R01 · FY2014 · CA
Clinical development of 18F PET tracer for imaging VEGF receptors$222,920
R44 · FY2014 · CA · contact PI
Image-guided combination therapy: noninvasive assessment of delivery and response$550,456
R01 · FY2013 · CA
Targeted delivery of Lu-177 to tumor vasculature$985,550
R44 · FY2012 · CA · contact PI
Image-guided combination therapy: noninvasive assessment of delivery and response$595,990
R01 · FY2012 · CA
Targeted delivery of Lu-177 to tumor vasculature$786,124
R44 · FY2011 · CA · contact PI
Image-guided combination therapy: noninvasive assessment of delivery and response$608,757
R01 · FY2011 · CA
Targeted photoacoustic imaging of VEGF receptors in angiogenic vasculature$286,918
R43 · FY2011 · EB · contact PI
Targeted delivery of Lu-177 to tumor vasculature$286,382
R43 · FY2009 · CA · contact PI
VEGF-based Targeted Imaging of Tumor Vasculature$564,762
R44 · FY2008 · CA · contact PI
VEGF-based Targeted Imaging of Tumor Vasculature$545,177
R44 · FY2007 · CA · contact PI
Targeting anti-apoptotic drugs to failing cardiomyocytes$187,130
R43 · FY2007 · HL · contact PI
VEGF-driven PET imaging of tumor angiogenesis$182,582
R43 · FY2007 · EB · contact PI
Molecular Targeted Imaging in Colon Cancer$162,918
R43 · FY2007 · CA · contact PI
Imaging Proteins Docked to Standard Radionuclide Module$150,137
R21 · FY2006 · EB · contact PI
VEGF-based targeted imaging of tumor vasculature$196,767
R43 · FY2005 · CA
Imaging Proteins Docked to Standard Radionuclide Module$175,000
R21 · FY2005 · EB
Pro-angiogenic Collagen Implants$183,750
R43 · FY2004 · GM
Targeted delivery of anti-anthrax therapeutics$107,000
R43 · FY2003 · AI
TARGETING ANGIOGENESIS WITH TOXIN-VEGF FUSION PROTEINS$613,618
R44 · FY2002 · CA
TARGETING ANGIOGENESIS WITH TOXIN VEGF FUSION PROTEINS$545,700
R44 · FY2001 · CA
NEW METHODOLOGY FOR VEGF-MEDIATED GENE DELIVERY$376,011
R44 · FY2001 · HL
NEW METHODOLOGY FOR VEGF-MEDIATED GENE DELIVERY$369,685
R44 · FY2000 · HL